Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/218277 |
Resumo: | Maple syrup urine disease (MSUD) is caused by an inborn error in metabolism resulting from a deficiency in the branched-chain a-keto acid dehydrogenase complex activity. This blockage leads to accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine and valine, as well as their corresponding a-keto acids and a-hydroxy acids. High levels of BCAAs are associated with neurological dysfunction and the role of proand mature brain-derived neurotrophic factor (BDNF) in the neurological dysfunction of MSUD is still unclear. Thus, in the present study we investigated the effect of an acute BCAA pool administration on BDNF levels and on the pro-BDNF cleavage-related proteins S100A10 and tissue plasminogen activator (tPA) in rat brains. Our results demonstrated that acute Hyper-BCAA (H-BCAA) exposure during the early postnatal period increases pro-BDNF and total-BDNF levels in the hippocampus and striatum. Moreover, tPA levels were significantly decreased, without modifications in the tPA transcript levels in the hippocampus and striatum. On the other hand, the S100A10 mRNA and S100A10 protein levels were not changed in the hippocampus and striatum. In the 30-day-old rats, we observed increased pro-BDNF, total-BDNF and tPA levels only in the striatum, whereas the tPA and S100A10 mRNA expression and the immunocontent of S100A10 were not altered. In conclusion, we demonstrated that acute H-BCAA administration increases the pro-BDNF/totalBDNF ratio and decreases the tPA levels in animals, suggesting that the BCAA effect may depend, at least in part, on changes in BDNF post-translational processing. |
id |
UFRGS-2_3eea0c0bec81eae58d9b3fac999b5397 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/218277 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Scaini, GiselliMorais, Meline Oliveira dos SantosFurlanetto, Camila B.Kist, Luiza WilgesPereira, Talita Carneiro BrandaoSchuck, Patrícia FernandaFerreira, Gustavo da CostaPasquali, Matheus Augusto de BittencourtGelain, Daniel PensMoreira, Jose Claudio FonsecaBogo, Mauricio ReisStreck, Emilio Luiz2021-02-26T04:13:24Z20150364-3190http://hdl.handle.net/10183/218277001047778Maple syrup urine disease (MSUD) is caused by an inborn error in metabolism resulting from a deficiency in the branched-chain a-keto acid dehydrogenase complex activity. This blockage leads to accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine and valine, as well as their corresponding a-keto acids and a-hydroxy acids. High levels of BCAAs are associated with neurological dysfunction and the role of proand mature brain-derived neurotrophic factor (BDNF) in the neurological dysfunction of MSUD is still unclear. Thus, in the present study we investigated the effect of an acute BCAA pool administration on BDNF levels and on the pro-BDNF cleavage-related proteins S100A10 and tissue plasminogen activator (tPA) in rat brains. Our results demonstrated that acute Hyper-BCAA (H-BCAA) exposure during the early postnatal period increases pro-BDNF and total-BDNF levels in the hippocampus and striatum. Moreover, tPA levels were significantly decreased, without modifications in the tPA transcript levels in the hippocampus and striatum. On the other hand, the S100A10 mRNA and S100A10 protein levels were not changed in the hippocampus and striatum. In the 30-day-old rats, we observed increased pro-BDNF, total-BDNF and tPA levels only in the striatum, whereas the tPA and S100A10 mRNA expression and the immunocontent of S100A10 were not altered. In conclusion, we demonstrated that acute H-BCAA administration increases the pro-BDNF/totalBDNF ratio and decreases the tPA levels in animals, suggesting that the BCAA effect may depend, at least in part, on changes in BDNF post-translational processing.application/pdfengNeurochemical research. New York, NY. Vol. 40, no. 5 (May. 2015), p. 885-893Doença da urina de xarope de bordoAminoácidos de cadeia ramificadaFator neurotrófico derivado do encéfaloAtivador de plasminogênio tecidualMaple syrup urine diseaseBranched-chain amino acidsBrain-derived neurotrophic factorTissue plasminogen activator, S100A10Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain.Estrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001047778.pdf.txt001047778.pdf.txtExtracted Texttext/plain0http://www.lume.ufrgs.br/bitstream/10183/218277/2/001047778.pdf.txtd41d8cd98f00b204e9800998ecf8427eMD52ORIGINAL001047778.pdfTexto completo (inglês)application/pdf3358676http://www.lume.ufrgs.br/bitstream/10183/218277/1/001047778.pdfd104d5ddb34f681edaf8ad9aef4a22c1MD5110183/2182772021-04-12 08:49:14.537437oai:www.lume.ufrgs.br:10183/218277Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-04-12T11:49:14Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
title |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
spellingShingle |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. Scaini, Giselli Doença da urina de xarope de bordo Aminoácidos de cadeia ramificada Fator neurotrófico derivado do encéfalo Ativador de plasminogênio tecidual Maple syrup urine disease Branched-chain amino acids Brain-derived neurotrophic factor Tissue plasminogen activator, S100A10 |
title_short |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
title_full |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
title_fullStr |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
title_full_unstemmed |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
title_sort |
Acute administration of branched-chain amino acids increases the Pro-BDNF/Total-BDNF ratio in the rat brain. |
author |
Scaini, Giselli |
author_facet |
Scaini, Giselli Morais, Meline Oliveira dos Santos Furlanetto, Camila B. Kist, Luiza Wilges Pereira, Talita Carneiro Brandao Schuck, Patrícia Fernanda Ferreira, Gustavo da Costa Pasquali, Matheus Augusto de Bittencourt Gelain, Daniel Pens Moreira, Jose Claudio Fonseca Bogo, Mauricio Reis Streck, Emilio Luiz |
author_role |
author |
author2 |
Morais, Meline Oliveira dos Santos Furlanetto, Camila B. Kist, Luiza Wilges Pereira, Talita Carneiro Brandao Schuck, Patrícia Fernanda Ferreira, Gustavo da Costa Pasquali, Matheus Augusto de Bittencourt Gelain, Daniel Pens Moreira, Jose Claudio Fonseca Bogo, Mauricio Reis Streck, Emilio Luiz |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Scaini, Giselli Morais, Meline Oliveira dos Santos Furlanetto, Camila B. Kist, Luiza Wilges Pereira, Talita Carneiro Brandao Schuck, Patrícia Fernanda Ferreira, Gustavo da Costa Pasquali, Matheus Augusto de Bittencourt Gelain, Daniel Pens Moreira, Jose Claudio Fonseca Bogo, Mauricio Reis Streck, Emilio Luiz |
dc.subject.por.fl_str_mv |
Doença da urina de xarope de bordo Aminoácidos de cadeia ramificada Fator neurotrófico derivado do encéfalo Ativador de plasminogênio tecidual |
topic |
Doença da urina de xarope de bordo Aminoácidos de cadeia ramificada Fator neurotrófico derivado do encéfalo Ativador de plasminogênio tecidual Maple syrup urine disease Branched-chain amino acids Brain-derived neurotrophic factor Tissue plasminogen activator, S100A10 |
dc.subject.eng.fl_str_mv |
Maple syrup urine disease Branched-chain amino acids Brain-derived neurotrophic factor Tissue plasminogen activator, S100A10 |
description |
Maple syrup urine disease (MSUD) is caused by an inborn error in metabolism resulting from a deficiency in the branched-chain a-keto acid dehydrogenase complex activity. This blockage leads to accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine and valine, as well as their corresponding a-keto acids and a-hydroxy acids. High levels of BCAAs are associated with neurological dysfunction and the role of proand mature brain-derived neurotrophic factor (BDNF) in the neurological dysfunction of MSUD is still unclear. Thus, in the present study we investigated the effect of an acute BCAA pool administration on BDNF levels and on the pro-BDNF cleavage-related proteins S100A10 and tissue plasminogen activator (tPA) in rat brains. Our results demonstrated that acute Hyper-BCAA (H-BCAA) exposure during the early postnatal period increases pro-BDNF and total-BDNF levels in the hippocampus and striatum. Moreover, tPA levels were significantly decreased, without modifications in the tPA transcript levels in the hippocampus and striatum. On the other hand, the S100A10 mRNA and S100A10 protein levels were not changed in the hippocampus and striatum. In the 30-day-old rats, we observed increased pro-BDNF, total-BDNF and tPA levels only in the striatum, whereas the tPA and S100A10 mRNA expression and the immunocontent of S100A10 were not altered. In conclusion, we demonstrated that acute H-BCAA administration increases the pro-BDNF/totalBDNF ratio and decreases the tPA levels in animals, suggesting that the BCAA effect may depend, at least in part, on changes in BDNF post-translational processing. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2021-02-26T04:13:24Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/218277 |
dc.identifier.issn.pt_BR.fl_str_mv |
0364-3190 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001047778 |
identifier_str_mv |
0364-3190 001047778 |
url |
http://hdl.handle.net/10183/218277 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Neurochemical research. New York, NY. Vol. 40, no. 5 (May. 2015), p. 885-893 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/218277/2/001047778.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/218277/1/001047778.pdf |
bitstream.checksum.fl_str_mv |
d41d8cd98f00b204e9800998ecf8427e d104d5ddb34f681edaf8ad9aef4a22c1 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447732609875968 |